PT-141 (Bremelanotide)
Central Nervous System Approach to Sexual Health
PT-141 (Bremelanotide) is a melanocortin receptor agonist that works through the central nervous system to address sexual dysfunction. Unlike PDE5 inhibitors that act on blood flow, PT-141 activates melanocortin-4 receptors in the brain to enhance sexual desire and arousal.
Starting at
$199/mo
MC4R
Receptor Target
CNS
Mechanism
SC
Administration
$199
Per Vial
How PT-141 Works
A unique approach targeting the brain's desire pathways rather than peripheral blood flow
Melanocortin-4 Activation
Binds to MC4 receptors in the hypothalamus, activating neural pathways associated with sexual desire and arousal — a fundamentally different approach from blood-flow medications.
Central Nervous System
Works through the CNS to enhance both desire and physical arousal, addressing the psychological component of sexual dysfunction.
Gender-Inclusive
Research has been conducted in both men and women, with studies showing benefits for hypoactive sexual desire disorder (HSDD) in women and erectile dysfunction in men.
Why Choose PT-141?
Enhanced Desire
Targets the brain's desire pathways for improved sexual motivation and interest.
Physical Arousal
Supports physical arousal response through central nervous system activation.
Works Differently
Complementary to PDE5 inhibitors — can be used when blood-flow medications are insufficient.
On-Demand Use
Administered as needed, typically 45 minutes before anticipated activity.
Both Genders
Studied in both men and women for sexual dysfunction conditions.
Non-Hormonal
Does not directly affect testosterone or estrogen levels.
PT-141 Protocol
On-demand dosing as directed by your provider
1-2mg as needed
Administered 45 min before anticipated activity
No more than 1 dose/24hrs
Maximum 8 doses per month recommended
Expected Results Timeline
All dosing determined by your prescribing provider. Not for daily use.
Frequently Asked Questions
PT-141 works through the central nervous system to enhance desire and arousal, while PDE5 inhibitors (Viagra, Cialis) work on blood flow. PT-141 addresses the desire component that blood-flow medications cannot.
Yes. PT-141 has been studied for hypoactive sexual desire disorder (HSDD) in premenopausal women. Your provider will assess whether it's appropriate for your situation.
Common side effects include nausea (usually mild and temporary), flushing, and headache. Taking an anti-nausea medication beforehand can help. Your provider will discuss management strategies.
PT-141 is used on-demand, not daily. Most protocols recommend no more than 8 doses per month with at least 24 hours between doses.
Restore Your Confidence
Start PT-141 therapy with a discreet provider consultation. Prepared by US-licensed 503A pharmacies.
Get Started NowFree medical consultation included • Cancel anytime